What is Smith Allergy?
Smith Allergy and Asthma Specialists is a dedicated provider of expert medical care for individuals experiencing allergies and asthma, serving both adult and pediatric populations. Under the leadership of Dr. Christopher Smith, the practice addresses a spectrum of conditions, including immune deficiencies, persistent nasal congestion, and food allergies. The company is also actively engaged in research, contributing to the United States Pollen Sampling Network to improve pollen data collection. Its reputation as the premier allergy center in the Finger Lakes and Twin Tiers regions highlights its established presence and recognized expertise in the healthcare sector.
How much funding has Smith Allergy raised?
Smith Allergy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Smith Allergy
PPP
Public-Private Partnership
What's next for Smith Allergy?
The substantial late-stage funding and strategic investment signal a pivotal moment for Smith Allergy and Asthma Specialists. This capital infusion is expected to fuel further expansion of services, potentially through enhanced research initiatives, broader patient outreach, or the development of new treatment modalities. The company's focus on specialized care for allergies and asthma, coupled with its commitment to data-driven research, positions it for continued growth and leadership in the medical field. This financing will likely enable strategic partnerships and operational scaling to meet increasing demand.
See full Smith Allergy company page
